Fate Therapeutics Appoints President and CEO

Biotechnology company Fate Therapeutics has appointed Christian Weyer as president and chief executive officer and also elected to the company's board of directors, effective immediately. William H. Rastetter, a partner at Venrock who has served as Fate's interim CEO since November 2011, will remain chairman of Fate's board of directors.

PeopleNorth AmericaUSBriefs